Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / *W EXP 08/27/202
-
Total 13F shares
-
528,391
-
Share change
-
+528,391
-
Total reported value
-
$1,544,000
-
Price per share
-
$2.90
-
Number of holders
-
12
-
Value change
-
+$1,544,000
-
Number of buys
-
12
Institutional Holders of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) as of Q3 2021
As of 30 Sep 2021,
Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
528,391 shares.
The largest 10 holders included
CVI Holdings, LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC, Sio Capital Management, LLC, Alpine Global Management, LLC, Exos Asset Management LLC, Warberg Asset Management LLC, LPL Financial LLC, P SCHOENFELD ASSET MANAGEMENT LP, and Verition Fund Management LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.